Impact of Airways Function After HFNC Evaluated by IOS

NACompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

December 13, 2019

Primary Completion Date

March 31, 2020

Study Completion Date

September 9, 2020

Conditions
Small Airway DisordersCOPD
Interventions
DEVICE

high flow nasal cannula and nasal cannula

"HFNC was administered using the MyAIRVO 2 device (Fisher \& Paykel Healthcare, Auckland, New Zealand), which provides humidification and high-flow medical gas through an Optiflow NC interface (Fisher \& Paykel Healthcare, Auckland, New Zealand) is administered for 10 min..~NC is administered for 10 min."

Trial Locations (1)

24205

Yen-Liang Kuo, New Taipei City

All Listed Sponsors
lead

Fu Jen Catholic University Hospital

OTHER

NCT05130112 - Impact of Airways Function After HFNC Evaluated by IOS | Biotech Hunter | Biotech Hunter